Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)

Exclusion Criteria

• •Patients in pregnancy or lactation
• •Long-term dialysis
• •Administration of any investigational drug within the previous 30 days
• •Intra-arterial or intravenous administration of iodinated contrast medium from 7 days before to 72 hours after the administration of study drug
• •Intake of any nephrotoxic medications 24 hours before or after the administration of study drug
• •Contraindications to the study drug or the cardiac catheterization procedure
• •Previous participation in this study
• •As the discretion of the investigator, the patient has any conditions not appropriate to the usage of iodinated contrast agent or not appropriate to undergo cardiac catheterization procedure